Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 261 participants.
Also called NCT01538875
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 261 participants
- Sponsor
- Saint Thomas Hospital, Panama
- Registry
-
NCT01538875
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Panama
- Registry status
- Completed
Technical summary
Registry record NCT01538875. Randomized; no masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of Pregnancy
- Condition
- Hypertension, Pregnancy Induced
- Intervention (Drug)
- Hydralazine
- Intervention (Drug)
- Labetalol
- Lead sponsor
- Saint Thomas Hospital, Panama
Record details
- Record id
cardio:ct-nct01538875- Content hash
9e8225e172e411ca087fde9fa6d2de4596661eeea1be32f5fde7ee77e2eb2fb5